Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Apr 28;5(1):e000924.
doi: 10.1136/rmdopen-2019-000924. eCollection 2019.

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults

Affiliations
Meta-Analysis

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults

Maria G Tektonidou et al. RMD Open. .

Abstract

Objective: To perform a systematic literature review (SLR) informing the European Lmmendations for the management of antiphospholipid syndrome (APS) in adults.

Methods: A SLR through January 2018 was performed. Research questions were constructed using the Patient, Intervention, Comparator, Outcome (PICO) format. We included data from articles that reported on each relevant intervention. Summary effect estimates were calculated for direct comparison studies that matched the PICO question exactly, and for studies with the relevant intervention and comparator. When meta-analyses were available, we used these estimates.

Results: From 7534 retrieved articles (+15 from hand searches), 188 articles were included in the review. In individuals with high-risk antiphospholipid antibody (aPL) profile without prior thrombotic or obstetric APS, two meta-analyses showed a protective effect of low-dose aspirin (LDA) against thrombosis. Two randomised controlled trials (RCTs) and three cohort studies showed no additional benefit of treatment with vitamin K antagonists at target international normalised ratio (INR) 3-4 versus INR 2-3 in patients with venous thrombosis. In patients with arterial thrombosis, two RCTs and two cohort studies showed no difference in risk of recurrent thrombosis between the two target INR groups. One open-label trial showed higher rates of thrombosis recurrences in triple aPL-positive patients treated with rivaroxaban than those treated with warfarin. RCTs and cohort studies showed that combination treatment with LDA and heparin was more effective than LDA alone in several types of obstetric APS. SLR results were limited by the indirect evidence and the heterogeneity of patient groups for some treatments, and only a few high-quality RCTs.

Conclusion: Well-designed studies of homogeneous APS patient populations are needed.

Keywords: antiphospholipid syndrome; management; pregnancy morbidity; recommendations; systematic literature review; systemic lupus erythematosus; thrombosis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flow chart of systematic literature review. APS, antiphospholipid syndrome.

References

    1. Miyakis S, Lockshin MD, Atsumi T, et al. . International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295–306. 10.1111/j.1538-7836.2006.01753.x - DOI - PubMed
    1. Tektonidou MG, Andreoli L, Limper M, et al. . EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. - PMC - PubMed
    1. Liberati A, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W–94. 10.7326/0003-4819-151-4-200908180-00136 - DOI - PubMed
    1. Sackett DL, Richardson WS, Rosenberg W, et al. . Evidence based medicine—how to practice and teach EBM. London: Churchill Livingstone, 1997.
    1. Higgins JPT, Altman DG, Gøtzsche PC, et al. . The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928 10.1136/bmj.d5928 - DOI - PMC - PubMed

Publication types

MeSH terms